0
     

Report Added
Report already added
Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market - Global Outlook and Forecast 2021-2027

Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market - Global Outlook and Forecast 2021-2027

This report contains market size and forecasts of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in global, including the following market information:
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs companies in 2020 (%)
The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market was valued at 1290.9 million in 2020 and is projected to reach US$ 1906.6 million by 2027, at a CAGR of 10.2% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Percentages, By Type, 2020 (%)
XIFAXAN
Viberzi
Lotronex
Other

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Percentages, By Application, 2020 (%)
Hospitals Pharmacy
Retail Pharmacy
Other

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs revenues share in global market, 2020 (%)
Key companies Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:
Bausch Health
Allergan
Sebela Pharmaceuticals
Astellas Pharmaceuticals
Amneal Pharms
Pharscin Pharma
1 Introduction to Research & Analysis Reports
1.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Sales Channel
1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Overall Market Size
2.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size: 2021 VS 2027
2.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players in Global Market
3.2 Top Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies Ranked by Revenue
3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Companies
3.4 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Companies
3.5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players in Global Market
3.8.1 List of Global Tier 1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size Markets, 2021 & 2027
4.1.2 XIFAXAN
4.1.3 Viberzi
4.1.4 Lotronex
4.1.5 Other
4.2 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue & Forecasts
4.2.1 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2016-2021
4.2.2 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2022-2027
4.2.3 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2016-2027
4.3 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales & Forecasts
4.3.1 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2016-2021
4.3.2 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2022-2027
4.3.3 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2016-2027
4.4 By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2021 & 2027
5.1.2 Hospitals Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue & Forecasts
5.2.1 By Application - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2016-2021
5.2.2 By Application - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2022-2027
5.2.3 By Application - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2016-2027
5.3 By Application - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales & Forecasts
5.3.1 By Application - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2016-2021
5.3.2 By Application - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2022-2027
5.3.3 By Application - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2016-2027
5.4 By Application - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2021 & 2027
6.2 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue & Forecasts
6.2.1 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2016-2021
6.2.2 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2022-2027
6.2.3 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2016-2027
6.3 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales & Forecasts
6.3.1 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2016-2021
6.3.2 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2022-2027
6.3.3 By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2016-2027
6.4.2 By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2016-2027
6.4.3 US Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.4.4 Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.4.5 Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2016-2027
6.5.2 By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2016-2027
6.5.3 Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.5.4 France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.5.5 U.K. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.5.6 Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.5.7 Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.5.8 Nordic Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.5.9 Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2016-2027
6.6.2 By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2016-2027
6.6.3 China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.6.4 Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.6.5 South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.6.6 Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.6.7 India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2016-2027
6.7.2 By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2016-2027
6.7.3 Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.7.4 Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, 2016-2027
6.8.3 Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.8.4 Israel Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.8.5 Saudi Arabia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
6.8.6 UAE Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Bausch Health
7.1.1 Bausch Health Corporate Summary
7.1.2 Bausch Health Business Overview
7.1.3 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.1.4 Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2016-2021)
7.1.5 Bausch Health Key News
7.2 Allergan
7.2.1 Allergan Corporate Summary
7.2.2 Allergan Business Overview
7.2.3 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.2.4 Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2016-2021)
7.2.5 Allergan Key News
7.3 Sebela Pharmaceuticals
7.3.1 Sebela Pharmaceuticals Corporate Summary
7.3.2 Sebela Pharmaceuticals Business Overview
7.3.3 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.3.4 Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2016-2021)
7.3.5 Sebela Pharmaceuticals Key News
7.4 Astellas Pharmaceuticals
7.4.1 Astellas Pharmaceuticals Corporate Summary
7.4.2 Astellas Pharmaceuticals Business Overview
7.4.3 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.4.4 Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2016-2021)
7.4.5 Astellas Pharmaceuticals Key News
7.5 Amneal Pharms
7.5.1 Amneal Pharms Corporate Summary
7.5.2 Amneal Pharms Business Overview
7.5.3 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.5.4 Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2016-2021)
7.5.5 Amneal Pharms Key News
7.6 Pharscin Pharma
7.6.1 Pharscin Pharma Corporate Summary
7.6.2 Pharscin Pharma Business Overview
7.6.3 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Major Product Offerings
7.6.4 Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales and Revenue in Global (2016-2021)
7.6.5 Pharscin Pharma Key News
8 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, Analysis
8.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity, 2016-2027
8.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Supply Chain Analysis
10.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Value Chain
10.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Upstream Market
10.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in Global Market
Table 2. Top Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Share by Companies, 2016-2021
Table 5. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales by Companies, (K Units), 2016-2021
Table 6. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Type
Table 9. List of Global Tier 1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), 2016-2021
Table 15. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), 2022-2027
Table 16. By Application – Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), 2016-2021
Table 20. By Application - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), 2022-2027
Table 21. By Region – Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), 2016-2021
Table 25. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), 2022-2027
Table 26. By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2016-2021
Table 29. By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2022-2027
Table 30. By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2016-2021
Table 33. By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2022-2027
Table 34. By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2016-2021
Table 37. By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2022-2027
Table 38. By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2016-2021
Table 41. By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales, (K Units), 2022-2027
Table 46. Bausch Health Corporate Summary
Table 47. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offerings
Table 48. Bausch Health Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Allergan Corporate Summary
Table 50. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offerings
Table 51. Allergan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Sebela Pharmaceuticals Corporate Summary
Table 53. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offerings
Table 54. Sebela Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. Astellas Pharmaceuticals Corporate Summary
Table 56. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offerings
Table 57. Astellas Pharmaceuticals Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Amneal Pharms Corporate Summary
Table 59. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offerings
Table 60. Amneal Pharms Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Pharscin Pharma Corporate Summary
Table 62. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Product Offerings
Table 63. Pharscin Pharma Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 64. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 65. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Capacity Market Share of Key Manufacturers, 2019-2021
Table 66. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Region, 2016-2021 (K Units)
Table 67. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production by Region, 2022-2027 (K Units)
Table 68. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Opportunities & Trends in Global Market
Table 69. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Drivers in Global Market
Table 70. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Restraints in Global Market
Table 71. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Raw Materials
Table 72. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Raw Materials Suppliers in Global Market
Table 73. Typical Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Downstream
Table 74. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Downstream Clients in Global Market
Table 75. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Distributors and Sales Agents in Global Market

List of Figures
Figure 1. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Type
Figure 2. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Segment by Application
Figure 3. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue in 2020
Figure 9. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2016-2027
Figure 10. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2016-2027
Figure 11. By Type - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2016-2027
Figure 13. By Application - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2016-2027
Figure 14. By Application - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2016-2027
Figure 16. By Region - Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2016-2027
Figure 17. By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2016-2027
Figure 18. By Country - North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2016-2027
Figure 19. US Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2016-2027
Figure 24. Germany Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. France Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2016-2027
Figure 33. China Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. India Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2016-2027
Figure 39. By Country - South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2016-2027
Figure 40. Brazil Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Market Share, 2016-2027
Figure 44. Turkey Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue, (US$, Mn), 2016-2027
Figure 48. Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Region, 2020 VS 2027
Figure 50. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industry Value Chain
Figure 51. Marketing Channels

Report Title: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market - Global Outlook and Forecast 2021-2027


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW